European Pharmaceutical Review

JULY 25, 2022

Consequently, pharmaceutical manufacturers risk their reputation if impersonating products fail to deliver the expected quality or health impact. Essentially, both counterfeit and falsified medicines pose risks to public health and threaten to undermine the healthcare system and pharmaceutical industry. About the author.

Pharmaceutical 104

Pharmaceutical Medicine Manufacturing Pharmaceutical manufacturing 104

World of DTC Marketing

DECEMBER 10, 2020

Among the 25 worldwide companies that spend the most on research and development—all more than $5 billion a year—seven are pharmaceutical manufacturers, but eight are automobile or automobile-parts companies with profit margins under 10 percent. Amazon’s operating margin is under 5 percent.

Insurance 181

Insurance Pharma Manufacturing Retail 181

European Pharmaceutical Review

DECEMBER 21, 2022

The healthcare industry is successful in innovating new treatment paradigms ranging from small molecular to biological therapeutics to personalised medicines. The healthcare industry is successful in innovating new treatment paradigms ranging from small molecular to biological therapeutics to personalised medicines.

Manufacturing 97

Manufacturing Pharmaceutical Healthcare Healthcare 97

PM360

AUGUST 26, 2024

Between 2015 and 2021, over a quarter of the drugs approved by the US Food and Drug Administration (FDA) were associated with specific biomarkers. When we talk about the future of precision medicine, we envision a harmonious union of healthcare and technology. That’s how money is saved and quality of life (QOL) is improved.

Medicine 52

Medicine Food and Drug Administration Government Insurance 52

Pharma Marketing Network

JUNE 11, 2020

And do that, you interviewed me back in 2015, for the results book. If you’re a pharmaceutical company or if you’re an agency or even a consultant. If there’s one evolution and I think this is impacting all of healthcare, pharma marketing is pretty specific. John Mack (PG): Yep.

Pharma 52

Pharma Marketing Media Healthcare 52

European Pharmaceutical Review

AUGUST 10, 2023

Amidst numerous warning letters distributed by the US Food and Drug Administration (FDA) to pharmaceutical manufacturers in recent months, in July this year, the US regulatory body published its analysis on drug product quality in 2022. In subsequent years, up to 2022, half this number or less were issued. Edge Biologicals Inc.,

FDA 98

FDA Food and Drug Administration Pharmaceutical Media 98